首页> 外文期刊>The Egyptian Journal of Hospital Medicine >Corneal Endothelial Changes after Iris-Claw Anterior Chamber Phakic Intraocular Lens Implantation
【24h】

Corneal Endothelial Changes after Iris-Claw Anterior Chamber Phakic Intraocular Lens Implantation

机译:虹膜爪前房眼人工晶状体植入术后角膜内皮的变化

获取原文
获取外文期刊封面目录资料

摘要

Background: Compared to other refractive surgeries, implantation of phakic intraocular lenses (pIOL) have more desirable results and are potentially reversible procedures due to the possibility of explanting these lenses. These methods usually do not require expensive or special surgical equipment and most ophthalmologists are able to perform these procedures., however disabilities resulting from pIOL are more severe compared to corneal refractive surgery. Due to the potential risk of damage to anterior segment structures, especially corneal endothelial cell loss, pIOL implantation is subjected to debate. Aim of the Work: To evaluate the endothelial cell count changes in eyes implanted with the iris-claw phakic lens for treatment of moderate to high myopia as regard changes in cell density. Patients and Methods: This study included Ten eyes of patients with moderate to high myopia implanted with The Iris-Claw Anterior Chamber Phakic Intraocular Lens at Al-Hussein University Hospital, In this prospective randomized study we did Preoperative specular microscopy and serial postoperative specular microscopy (Topcon SP- 1P, Topcon Medical Inc., Japan).) were performed to evaluate endothelial cell count changes over 6 months. Endothelial cell images were collected in the central region of the cornea before surgery and 1 and 6 months after surgery. The main outcome measures were central corneal ECD and the percentage of corneal endothelial cell loss. Secondary outcome measures were UCVA, BCVA, manifest refraction, and complications. Results: Preoperative mean endothelial cell count was 3198.50 ? 444.67 cells/ mm? (range, 2715.00 ? 3846.00 cells/ mm?)., it was 3074.50 ? 410.76 cells/ mm? (range, 2609.00 ? 3686.00 cells/ mm?) at 1 month after surgery., 3003.00 ? 411.91cells/ mm? (range, 2532.00 ? 3610.00cells/ mm?) at 6 months after surgery. The mean endothelial cell loss was 6.07% at the end of the follow up period with 3.79% at one month postoperative, 2.37% from one to six months postoperative. The mean BCVA improved from 0.27 ? 0.09 preoperatively to 0.44 ? 0.12 postoperatively and the mean UCVA, from 0.02 ? 0.01 to 0.33 ? 0.09 postoperatively, the mean SE was -0.93 ?0.57 D Postoperatively. Conclusion: Artisan phakic IOL had excellent results including., their suitability for high myopes, reversibility, high optical quality, predictability, safety, efficacy, potential gain in visual acuity in myopic patients and did not produce significant corneal endothelial cell loss 6months after surgery.
机译:背景:与其他屈光手术相比,有晶状体人工晶状体(pIOL)的植入具有更理想的效果,并且由于可植入这些晶状体而具有潜在的可逆性。这些方法通常不需要昂贵或特殊的手术设备,并且大多数眼科医生能够执行这些程序,但是与角膜屈光手术相比,pIOL导致的残疾更为严重。由于前段结构受损的潜在风险,尤其是角膜内皮细胞丢失的风险,pIOL植入引起了争论。工作目的:评估植入虹膜爪晶状体晶体以治疗中度至高度近视的眼睛中内皮细胞计数的变化,以了解细胞密度的变化。患者和方法:这项研究包括Al-Hussein大学医院的10眼中度至高度近视患者植入虹膜-爪前房相眼人工晶状体。在这项前瞻性随机研究中,我们进行了术前镜检和系列术后镜检(进行Topcon SP-1P,Topcon Medical Inc.,日本)以评估6个月内内皮细胞计数的变化。术前以及术后1个月和6个月在角膜中心区域收集内皮细胞图像。主要结局指标为中央角膜ECD和角膜内皮细胞损失百分比。次要结果指标为UCVA,BCVA,明显屈光和并发症。结果:术前平均内皮细胞计数为3198.50? 444.67格/毫米? (范围为2715.00-3846.00格/ mm?)。结果为3074.50-(mm)。 410.76格/毫米? (范围2609.00-3686.00细胞/ mm?)在手术后1个月时为3003.00? 411.91cells / mm? (范围2532.00?3610.00cells / mm?)在手术后6个月。随访期末平均内皮细胞损失为6.07%,术后1个月为3.79%,术后1至6个月为2.37%。平均BCVA从0.27提高术前0.09至0.44?术后0.12,平均UCVA从0.02开始。 0.01至0.33?术后0.09,平均SE为-0.93±0.57D。结论:有晶状体晶状体眼人工晶状体具有出色的结果,包括适合高度近视眼,可逆性,高光学质量,可预测性,安全性,疗效,近视眼患者视力的潜在增加,并且术后6个月未产生明显的角膜内皮细胞损失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号